Abstract
Physiologic data provide abundant documentation for the blood pressure regulatory role of the renin-angiotensin system to be exercised through its capacity for altering the levels of circulating angiotensin II [22, 7, 13]. Although angiotensin II is the only product of this system that has a direct vasoconstrictor effect and should correlate directly with blood pressure readings, its measurement is more difficult than the measurement of renin activity, and hence data on that correlation are limited [22, 4, 2]. Plasma renin activity is the variable component of this regulatory system most often measured, and from this single determination inferences are made about the physiologic state of the renin-angiotensin system and indirectly about the level of circulating angiotensin II [3, 25, 8]. In fact, several components of the renin-angiotensin system may exert an important and variable influence upon the rate of angiotensin II production and upon plasma angiotensin II concentrations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beckerhoff R, Luetscher JA, Wilkinson R, Gonzales C, Nokes GW: Plasma renin concentration, activity and substrate in hypertension induced by oral contraceptives. J Clin Endocrinol Metab 34: 1067, 1972
Brown JJ, Lever AF, Morton JJ, Frazer R, Love DR, Robertson JIS: Raised plasma angiotensin II and aldosterone during dietary sodium restriction in man. Lancet 2: 1106, 1972
Brunner HR, Laragh JH, Baer L, Newton MA, Goodwin FT, Krakoff LR, Bard RH, Buhler FR: Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med 286: 441, 1972
Gocke DJ, Gerten J, Sherwood LN, Laragh JH: Physiological and pathological variations of plasma angiotensin II in man. Circ Res 24 (Suppl 1): 131, 1969
Gould AB, Green D: Kinetics of the human renin and human substrate reaction. Cardiovasc Res 5: 86, 1971
Gould AB, Skeggs LT, Joseph K: Measurement of renin and substrate concentration in human serum. Lab Invest 15: 1802, 1966
Haber E, Koerner T, Page LB, Kliman B, Purnod EA: Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 29: 1349, 1969
Helmer OM: Renin activity in blood from patients with hypertension. Can Med Assoc J 90: 221, 1964
Kotchen TA, Talwalker RT, Kotchen JN, Miller MC, Welch WJ: Evidence for the existence of an acetone soluble inhibiting factor in normal human plasma. Circ Res 36/37 (Suppl I): 17, 1975
Kotchen TA, Talwalker RT, Miller MC, Welch WJ: Modification of renin reactivity by lipds extracted from normal, hypertensive and uremic plasma. J Clin Endocrinol Metab 43: 971, 1976
Krakoff LR: Plasma renin substrate: measurement by radioimmunoassay of angiotensin I concentration in syndromes associated with steroid excess. J Clin Endocrinol Metab 37: 110, 1973
Needleman P, Johnson EM Jr, Vine W, et al.: Pharmacology of antagonists of angiotensin I and II. Circ Res 31: 862, 1972
Peach MJ: Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 57: 313, 1977
Saito H, Hermann J, Walker WG: Kinetic studies of renin-angiotensin system in plasma from normotensive and hypertensive subjects. In: Abstracts of sixth scientific meeting of the International society of hypertension, Goteborg, Sweden, 1979
Sambhi MP: Renin substrate reaction. Circ Res 41 (Suppl II): 1, 1977
Sambhi MP, Eggena P, Barrett JD, Tuck M, Wiedeman CE, Thananopavarn C: A circulating renin activator in essential hypertension. Circ Res 36 (Suppl I): 1–28, 1975
Segal IH: Enzyme kinetics: behavior and analysis of rapid equilibrium and steady state enzyme system. John Wiley and Sons, 1975
Skinner SL, Lumbers ER, Symonds EM: Alterations by oral contraceptives and of normal menstrual changes on plasma renin activity, concentration and substrate. Clin Sci 36: 67, 1967
Walker WG, Horvath JS, Moore MA, Russell RP: Some observations on arterial and venous levels of angiotensin II in man. Trans Am Clin Climat Assoc 85: 151, 1973
Walker WG, Horvath JS, Moore MA, Russell RP, Conti CR, Mitch WE: Pulmonary generation and peripheral uptake of endogenous angiotensin II in man. Trans Assoc Am Phys 86: 226, 1973
Walker WG, Horvath JS, Moore MA, Whelton PK, Russell RP: Relation between plasma renin activity and aldosterone in mild untreated hypertension. Circ Res 38: 470, 1976
Walker WG, Moore MA, Horvath JS, Whelton PK: Arterial and venous angiotensin II in normal subjects: relation to plasma renin activity and plasma aldosterone concentration, in response to posture and volume. Circ Res 38: 477, 1976
Walker WG, Ross RS, Hammond JDS: Study of the relationship between plasma volume and transcapillary protein exchange using 131I labeled albumin and 125I labeled globulin. Circ Res 8: 1028, 1960
Walker WG, Whelton PK, Saito H, Russell RP, Hermann J: Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone, urinary sodium and potassium in 574 subjects. Hypertension 1: 287, 1979
Woods JW, Pittman AW, Pulliam CC, Werk EE, Waider W, Allen CA: Renin profiling in hypertension and its use in treatment with propranolol and chlorthalidone. N Engl J Med 294: 1137, 1976
Workman RJ, McKown MM, Greggerman RI: Renin inhibition by protein and peptides. Biochemistry 13: 3029, 1974
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishers, Boston/The Hague/Dordrecht/Lancaster
About this chapter
Cite this chapter
Walker, W.G., Saito, H. (1984). The Relation of Plasma Renin Substrate to Blood Pressure in Essential Hypertension. In: Sambhi, M.P. (eds) Fundamental Fault in Hypertension. Developments in Cardiovascular Medicine, vol 36. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-5678-0_25
Download citation
DOI: https://doi.org/10.1007/978-94-009-5678-0_25
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-9006-3
Online ISBN: 978-94-009-5678-0
eBook Packages: Springer Book Archive